Evidence map›Paper›PMID 32475039›Full record

ArticleArthritis care & research2021

Obesity and the Risk of Incident Chronic Opioid Use in Rheumatoid Arthritis.

Joshua F Baker, Andrew Stokes, Sofia Pedro, Ted R Mikuls, Michael George, Bryant R England, Harlan Sayles, Fred Wolfe, Kaleb Michaud

Open access · greenAbstract read
In one paragraph

Article in Arthritis care & research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Observational
  4. Hypertension in connective tissue disease.Journal of human hypertension · 2024
    Review
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Joshua F BakerPhiladelphia VA Medical Center and University of Pennsylvania, Philadelphia.ORCID 0000-0003-0799-7563
Andrew StokesBoston University School of Public Health, Boston, Massachusetts.
Sofia PedroFORWARD, The National Databank for Rheumatic Diseases, Wichita, Kansas.
Ted R MikulsVA Nebraska-Western Iowa Health Care System and University of Nebraska Medical Center, Omaha.ORCID 0000-0002-0897-2272
Michael GeorgeUniversity of Pennsylvania, Philadelphia.ORCID 0000-0002-0398-2308
Bryant R EnglandVA Nebraska-Western Iowa Health Care System and University of Nebraska Medical Center, Omaha.ORCID 0000-0002-9649-3588
Harlan SaylesVA Nebraska-Western Iowa Health Care System and University of Nebraska Medical Center, Omaha.
Fred WolfeFORWARD, The National Databank for Rheumatic Diseases, Wichita, Kansas.ORCID 0000-0002-2801-6413
Kaleb MichaudFORWARD, The National Databank for Rheumatic Diseases, Wichita, Kansas, and VA Nebraska-Western Iowa Health Care System and University of Nebraska Medical Center, Omaha, Nebraska.ORCID 0000-0002-5350-3934
The National Databank for Rheumatic Diseases · USVA Nebraska Western Iowa Health Care System · USBoston University · USPhiladelphia VA Medical Center · USUniversity of Pennsylvania · US

Funding

Tracking and Evaluation CoreU54GM115458 · NIGMS · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI GUDA, CHITTIBABU · 2016 to 2025
$42.8M
Environmental Factors and Autoantibody Expression in Rheumatoid ArthritisI01CX000896 · VA · OMAHA VA MEDICAL CENTER · PI MIKULS, TED RICHARD · 2014 to 2017
–
Adipokines as Biomarkers of Cachexia and High-Risk Rheumatoid ArthritisI01CX001703 · VA · PHILADELPHIA VA MEDICAL CENTER · PI BAKER, JOSHUA F. · 2019 to 2023
–
CSRD VA I01 CX000896CSRD VA I01 CX001703NIGMS NIH HHS U54 GM115458NIGMS NIH HHS U54GM115458Rheumatology Research FoundationRRD VA I01 RX003644U.S. Department of Veterans Affairs CX000896U.S. Department of Veterans Affairs CX001703
6 · The paper itself

Abstract

objectiveThe present study was undertaken to evaluate whether the rate of incident chronic opioid use is higher in obese patients with rheumatoid arthritis (RA).

methodsParticipants with RA in the FORWARD databank were asked about their use of weak and strong opioid medications on semiannual surveys. Incident chronic opioid use was defined as new reported use extending over 2 contiguous surveys (~7-12 months). Cox proportional hazards models were used to evaluate associations between body mass index (BMI) at enrollment and incident chronic opioid use (overall use and strong opioid use). Models adjusted for demographics, smoking, disease duration, RA treatments, household income, and education level. The predicted 5-year cumulative incidence was calculated from Cox models.

resultsAmong 19,794 participants, 2,802 experienced an incident episode of chronic opioid use over 93,254 person-years of follow-up. Higher BMI was associated with higher risk of chronic opioid use. Severe obesity (BMI >35 kg/m

conclusionObesity is associated with a substantially higher risk of incident chronic opioid use. Approximately 1 in 4 cases of incident use of strong opioids may be attributable to obesity, suggesting a major public health impact. Interventions to prevent or reduce obesity could have an important impact on the use of opioids.

Indexed as

AdultAgedAnalgesics, OpioidArthritis, RheumatoidBody Mass IndexChronic PainFemaleHealth Care SurveysHumansLongitudinal StudiesMaleMiddle AgedObesityRegistriesRisk AssessmentRisk FactorsAnalgesics, Opioid

Identifiers

PMID32475039
PMCPMC7704711
OpenAlexW3029441554

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.